Moolec Science SA Ordinary Shares (NASDAQ:MLEC) — Market Cap & Net Worth
Market Cap & Net Worth: Moolec Science SA Ordinary Shares (MLEC)
Moolec Science SA Ordinary Shares (NASDAQ:MLEC) has a market capitalization of $4.38 Million ($4.38 Million) as of September 18, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #28926 globally and #5918 in its home market, demonstrating a -12.99% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Moolec Science SA Ordinary Shares's stock price $6.03 by its total outstanding shares 726118 (726.12K). Also see Moolec Science SA Ordinary Shares total assets for a full breakdown of the balance sheet.
Moolec Science SA Ordinary Shares Market Cap History: 2021 to 2026
Moolec Science SA Ordinary Shares's market capitalization history from 2021 to 2026. Data shows change from $7.16 Million to $4.38 Million (-8.40% CAGR). Also see MLEC cash generation efficiency for how efficiently the company converts equity into cash flow.
Index Memberships
Moolec Science SA Ordinary Shares is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Composite
IXIC
|
$41.69 Trillion | 0.00% | #2684 of 3165 |
Weight: Moolec Science SA Ordinary Shares's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Moolec Science SA Ordinary Shares Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Moolec Science SA Ordinary Shares's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check MLEC share price today for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.00x
Moolec Science SA Ordinary Shares's market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2023 | $1.79 Million | $905.05K | -$51.79 Million | 1.97x | N/A |
| 2024 | $586.85K | $5.63 Million | -$7.31 Million | 0.10x | N/A |
| 2025 | $184.87K | $333.61 Million | -$111.46 Million | 0.00x | N/A |
Competitor Companies of MLEC by Market Capitalization
Companies near Moolec Science SA Ordinary Shares in the global market cap rankings as of September 18, 2026. Review MLEC intangible-adjusted equity ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Moolec Science SA Ordinary Shares by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #187 globally with a market cap of $130.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #353 globally with a market cap of $78.34 Billion USD.
- CSL Ltd (AU:CSL): Ranked #457 globally with a market cap of $59.87 Billion USD ( AU$84.62 Billion AUD).
- Moderna Inc (NASDAQ:MRNA): Ranked #505 globally with a market cap of $54.14 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #187 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $130.09 Billion | $513.26 |
| #353 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $78.34 Billion | $774.61 |
| #457 | CSL Ltd | AU:CSL | $59.87 Billion | AU$174.41 |
| #505 | Moderna Inc | NASDAQ:MRNA | $54.14 Billion | $145.62 |
Moolec Science SA Ordinary Shares Historical Marketcap From 2021 to 2026
Between 2021 and today, Moolec Science SA Ordinary Shares's market cap moved from $7.16 Million to $ 4.38 Million, with a yearly change of -8.40%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $4.38 Million | +2268.42% |
| 2025 | $184.87K | -68.50% |
| 2024 | $586.85K | -67.15% |
| 2023 | $1.79 Million | -79.67% |
| 2022 | $8.79 Million | +22.72% |
| 2021 | $7.16 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 17th, 2026 the market cap of Moolec Science SA Ordinary Shares was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $4.38 Million USD |
| MoneyControl | $4.38 Million USD |
| MarketWatch | $4.38 Million USD |
| marketcap.company | $4.38 Million USD |
| Reuters | $4.38 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Moolec Science SA Ordinary Shares
Moolec Science SA, a science-based ingredient company, engages in the development of ingredients for food, pet food, animal feed, and dietary supplements using molecular farming technology and precision fermentation platforms in Cayman Islands and internationally. It develops nutritional supplements, food ingredients, meat replacements, and by-products using safflowers, chickpeas, fungi, soybeans… Read more